Edition:
United States

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

7.62USD
11:02am EST
Change (% chg)

$-0.06 (-0.78%)
Prev Close
$7.68
Open
$7.63
Day's High
$7.88
Day's Low
$7.62
Volume
900
Avg. Vol
8,291
52-wk High
$16.09
52-wk Low
$7.43

Latest Key Developments (Source: Significant Developments)

Iridex Corp reports qtrly loss per share $0.27‍​
Thursday, 2 Nov 2017 04:04pm EDT 

Nov 2 (Reuters) - Iridex Corp :Iridex announces 2017 third quarter financial results.Q3 revenue rose 11 percent to $10.9 million.Iridex Corp - ‍Iridex reiterates its previously provided estimate for revenue, and g6 system and g6 probe shipments for full year 2017​.Iridex Corp - qtrly loss per share $0.27‍​.  Full Article

Iridex Q2 revenue falls 16 pct
Thursday, 3 Aug 2017 04:03pm EDT 

Aug 3 (Reuters) - Iridex Corp ::Iridex announces 2017 second quarter, six-month financial results.Q2 revenue fell 16 percent to $10 million.Sees FY 2017 revenue $43 million to $46 million.Iridex Corp - qtrly ‍net loss per share $ 0.24​.Iridex sees ‍fy 2017 reduced anticipated sales of g6 systems to a range of 350 to 400 and g6 probe shipments to range of 30,000 to 35,000​.Iridex - ‍continues to expect revenue growth to be more heavily weighted towards second half of 2017​.Iridex sees ‍revenue from its medical retina and surgical retina businesses will decline in mid-to-high single digits for fy 2017​.  Full Article

Iridex Q1 revenue fell 12 percent to $10.5 million
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Iridex Corp :Iridex announces first quarter 2017 financial results.Q1 revenue fell 12 percent to $10.5 million.Sees FY 2017 revenue $46 million to $49 million.Iridex-Continues to anticipate for full year 2017 sales of 400 to 450 g6 systems, currently expects g6 probe shipments to range from 35,000 to 40,000.Iridex Corp qtrly loss per share $0.16.Iridex-For full year 2017 expects revenue from its medical retina business will decline in low single digits with some "quarter-to-quarter lumpiness".Iridex Corp - For full year 2017 expects revenue from surgical retina business will continue to decline in mid-to-high single digits.Iridex Corp - Revenue growth is expected to be more heavily weighted towards second half of 2017.  Full Article

Iridex says entered into agreement to amend securities purchase agreement among
Friday, 21 Apr 2017 04:59pm EDT 

April 21 (Reuters) - Iridex Corp ::Iridex-On april 20, co entered into an agreement to amend that certain securities purchase agreement among co, Blueline Capital Partners, Lp, others.Iridex -pursuant to amendment,blueline,others,waived their right to designate a nominee for nomination to co's board prior to march 31, 2018-sec filing.  Full Article

Iridex reports Q4 loss per share of $1.04
Wednesday, 8 Mar 2017 04:03pm EST 

Iridex Corp : Iridex announces fourth quarter and 2016 financial results and provides full year 2017 financial outlook . Q4 revenue rose 67 percent to $12.5 million . Sees FY 2017 revenue $48 million to $52 million . sold 96 cyclo g6 systems and shipped approximately 8,000 g6 probes in Q4 of 2016 . FY2017 revenue view $51.9 million -- Thomson Reuters I/B/E/S . Company anticipates that in 2017, it will sell 400 to 450 cyclo g6 laser systems and ship 45,000 to 50,000 g6 probes . Iridex corp - in 2017, we anticipate revenue growth to be more heavily weighted towards second half of year . In 2017, anticipate revenue growth to be more heavily weighted towards second half of year as start to see full benefits of growth investments .Qtrly loss per share $1.04.  Full Article

Iridex announces preliminary unaudited revenues for 2016 Q4 and FY
Monday, 9 Jan 2017 06:00am EST 

Iridex Corp : Iridex announces preliminary unaudited revenues for 2016 fourth quarter and full year . Q4 preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for full year 2016 .Iridex Corp - Revenue growth compared to Q4 and full year 2015 was driven by company's new flagship Cyclo G6 glaucoma laser platform.  Full Article

Iridex Corporation announces proposed public offering of common stock
Thursday, 8 Dec 2016 04:31pm EST 

Iridex Corp : Iridex Corp - intends to offer newly issued shares of common stock, $0.01 par value pursuant to an underwritten public offering . Intends to offer newly issued shares of common stock, $0.01 par value .Iridex Corporation announces proposed public offering of common stock.  Full Article

Iridex reports 2016 third quarter, nine-month results
Thursday, 3 Nov 2016 04:05pm EDT 

Iridex Corp : Iridex Corp- continues to expect revenue growth for full year 2016 to be in low double-digits . Iridex Corp- for Q4 of 2016, company anticipates revenues of $12.4 million to $12.9 million . Iridex reports 2016 third quarter, nine-month results . Q3 loss per share $0.07 . Sees Q4 2016 revenue $12.4 million to $12.9 million .Q3 revenue $9.8 million versus $9.8 million.  Full Article

Iridex Q3 preliminary revenues of approximately $9.6 to $9.7 mln
Tuesday, 11 Oct 2016 04:05pm EDT 

Iridex Corp : Iridex announces preliminary revenues for 2016 third quarter . Preliminary revenues of approximately $9.6 to $9.7 million for q3 ended october 1, 2016 . Iridex - while demand for Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations ."demand for company's new flagship Cyclo G6 laser platform for glaucoma remained strong".  Full Article

Iridex sees Q3 revenue $11 million to $11.3 million
Thursday, 4 Aug 2016 04:05pm EDT 

Iridex Corp : Q2 loss per share $0.03 . Q2 revenue rose 32 percent to $11.9 million . Month results . Sees Q3 2016 revenue $11 million to $11.3 million . Company continues to expect revenue growth for full year 2016 to be in low double-digits .Expect higher revenue in q4 relative to q3 due to typical seasonality.  Full Article

BRIEF-Iridex Corp reports qtrly loss per share $0.27‍​

* Iridex Corp - ‍Iridex reiterates its previously provided estimate for revenue, and g6 system and g6 probe shipments for full year 2017​